Communicable disease threats report, Week 33, 9 - 15 August 2015
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 9-15 August 2015, and includes updates on meningococcal disease, West Nile virus, polio, Ebola virus, MERS and chikungunya.
Communicable disease threats report, 16-22 August 2015, week 34
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 16-22 August 2015 , and includes updates on chikungunya, West Nile virus, meningococcal disease, polio, Ebola virus and MERS.
Communicable disease threats report, 4-10 February 2018, week 6
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 4-10 February 2018 and includes updates on poliomyelitis, hepatitis A, seasonal influenza, rubella, measles, meningitis, mass gathering monitoring (Olympics) and yellow fever.
Rapid risk assessment: Public health risks related to communicable diseases during the hajj 2019, Saudi Arabia, 9–14 August 2019
In 2019, the hajj will take place between 9 and 14 August. The risk for EU/EEA citizens to become infected with communicable diseases during the 2019 hajj is considered low, thanks to the vaccination requirements for travelling to Makkah (Mecca) and the Saudi Arabian preparedness plans that address the management of health hazards during and after hajj.
- Food- and waterborne diseases
- Hepatitis A
- Hepatitis B
- Mass gathering
- Meningococcal disease
- Middle East respiratory syndrome coronavirus
- Public health threat
- Saudi Arabia
- Travellers' health
- Vaccine preventable diseases
- Vector-borne disease
Risk assessment guidelines for infectious diseases transmitted on aircraft
In the closed cabin environment of modern airplanes, passengers are frequently exposed to various infectious diseases. This report looks at 12 infectious diseases and, by systematically evaluating literature on on-board transmission, attempts to assess the risk of infection via air circulation in airplanes.
These guidelines are complemented by operational guidelines in relation to tuberculosis, new emerging airborne diseases (e.g. SARS) and meningococcal infections.